Australian court hands out gun-jumping fine
An Australian biotechnology company must pay a A$1.05 million (€660,387) penalty for signing an agreement to direct its customers to the company that was purchasing some of its assets before the deal actually completed, the country’s Federal Court has held.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10